Viewing Study NCT01545804


Ignite Creation Date: 2025-12-24 @ 9:11 PM
Ignite Modification Date: 2026-01-05 @ 5:44 PM
Study NCT ID: NCT01545804
Status: COMPLETED
Last Update Posted: 2017-02-09
First Post: 2012-03-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Lenalidomide as Second-line Treatment for Advanced Hepatocellular Carcinoma
Sponsor: National Taiwan University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module